MedPath

APREMILAST SANDOZ 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

APREMILAST SANDOZ 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

89699

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jul 12, 2024

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89699
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

APREMILASTActive
Quantity: 30 mg
Name: APREMILAST

ATC CLASSIFICATION (3)

L04A
L04AA
L04AA32

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.